ID-FISH Technology, Inc

ID-FISH Technology is a clinical laboratory diagnostics supplier specializing in fluorescence in situ hybridization (FISH) and ImmunoBlot testing technologies for the detection of tick-borne diseases and other pathogens. The company has over 15 years of experience developing diagnostic assays using patented FISH and ImmunoBlot methodologies. FISH technology detects and locates specific DNA sequences on chromosomes with greater sensitivity and specificity than traditional Giemsa-stained smear methods. ImmunoBlot tests determine the presence of pathogen-specific antibodies in patient serum or plasma using recombinant antigens, offering superior sensitivity and specificity compared to Western Blot or ELISA assays. The company's product portfolio includes FDA-cleared Lyme ImmunoBlot kits (iDart Lyme IgM and IgG), which feature 26 and 31 Lyme antigen bands respectively—more than competing immunoblot tests—and uniquely detect antibodies to Osp A (P31) and Osp B (P34) antigens. Products are designed for clinical laboratory use and meet FDA clearance requirements. The company serves clinical laboratory markets requiring sensitive, specific diagnostic testing capabilities for infectious disease detection.